(Q40883160)

24 September 2017

title

Aminoguanidine-mediated inactivation and alteration of neuronal nitric-oxide synthase (English)

1 reference

24 September 2017

Jianmongkol S

1

1 reference

24 September 2017

Vuletich JL

2

1 reference

24 September 2017

Bender AT

3

1 reference

24 September 2017

Demady DR

4

1 reference

24 September 2017

Osawa Y

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Journal of Biological Chemistry

24 September 2017

published in

1 reference

24 September 2017

volume

275

1 reference

24 September 2017

issue

18

1 reference

24 September 2017

page(s)

13370-13376

1 reference

Nitric oxide synthase is a cytochrome P-450 type hemoprotein

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

High-level expression of functional rat neuronal nitric oxide synthase in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Approaches toward selective inhibition of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

The arginine-nitric oxide pathway: a target for new drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Selective pharmacological inhibition of distinct nitric oxide synthase isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Inhibition of nitric oxide formation by aminoguanidine: an attempt to prevent insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Neuronal nitric-oxide synthase is regulated by the Hsp90-based chaperone system in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Chemiluminescence assay for oxidatively modified myoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Covalent bonding of the prosthetic heme to protein: a potential mechanism for the suicide inactivation or activation of hemoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Neuronal nitric oxide synthase. Expression in Escherichia coli, irreversible inhibition by phenyldiazene, and active site topology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Degradation of cytochrome P450 2E1: Selective loss after labilization of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Nitric oxide synthase inhibitors: amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Characterization of the inactivation of nitric oxide synthase by NG-methyl-L-arginine: evidence for heme loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.18.13370

21 January 2018

Identifiers

DOI

10.1074/JBC.275.18.13370

1 reference

24 September 2017

1 reference